Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK.
Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Ultrasound Obstet Gynecol. 2024 Sep;64(3):308-313. doi: 10.1002/uog.27632. Epub 2024 Aug 4.
Women with a hypertensive disorder of pregnancy (HDP) are at increased risk of developing hypertension and cardiovascular disease later in life. However, from previous studies, it is difficult to define whether this association reflects pre-existing maternal cardiovascular risk or a potentially causal relationship between HDP and later cardiovascular risk. In this study, we performed detailed cardiovascular assessment in women in midgestation, prior to development of HDP, and at 2 years postpartum, aiming to identify cardiovascular changes prior to development of HDP and to assess persistent cardiovascular alterations long after the HDP event.
This was a prospective observational study in which we performed detailed cardiovascular assessment in midgestation and at a median of 2.3 (interquartile range, 2.1-2.4) years postpartum. We examined 112 women who developed HDP and 451 women whose pregnancy was not complicated by hypertension. We used conventional and more advanced (i.e. speckle tracking) echocardiographic techniques to determine accurately left ventricular systolic and diastolic function. We used M-mode measurements to determine left ventricular remodeling and estimate left ventricular mass. Maternal vascular status was assessed using ophthalmic artery Doppler and by calculating peak systolic velocity (PSV) ratio, as a marker of peripheral vascular resistance.
In midgestation, women who subsequently developed HDP had increased ophthalmic artery PSV ratio. These women also had mild cardiac functional and morphological alterations, which were accounted for mostly by maternal cardiovascular risk factors. At 2 years postpartum, women who had experienced HDP, compared to those who did not, had cardiovascular abnormalities with reduction in left ventricular systolic and diastolic function, which remained after multivariable analysis. Longitudinal analysis demonstrated that the evolution of cardiovascular changes in the HDP and non-HDP groups was similar.
Mild cardiac functional and morphological alterations precede the development of HDP and such changes persist for at least 2 years postpartum. The cardiac changes are likely to be the consequence of pre-existing maternal cardiovascular risk factors rather than an adverse consequence of HDP. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
患有妊娠高血压疾病(HDP)的女性在以后的生活中患高血压和心血管疾病的风险增加。然而,从以往的研究中很难确定这种关联是反映了母体心血管疾病的潜在风险,还是 HDP 与以后的心血管风险之间的潜在因果关系。在这项研究中,我们在 HDP 发生之前的妊娠中期对女性进行了详细的心血管评估,并在产后 2 年时进行了评估,旨在确定 HDP 发生前的心血管变化,并评估 HDP 事件后长期的持续心血管改变。
这是一项前瞻性观察性研究,我们在妊娠中期和产后中位数 2.3 年(四分位距,2.1-2.4 年)进行了详细的心血管评估。我们检查了 112 名患有 HDP 的女性和 451 名妊娠无高血压的女性。我们使用传统和更先进的(即斑点追踪)超声心动图技术来准确地确定左心室收缩和舒张功能。我们使用 M 模式测量来确定左心室重构并估计左心室质量。通过眼动脉多普勒和计算峰值收缩速度(PSV)比作为外周血管阻力的标志物来评估母体血管状态。
在妊娠中期,随后发展为 HDP 的女性眼动脉 PSV 比增加。这些女性也有轻度的心脏功能和形态改变,这些改变主要归因于母体心血管危险因素。在产后 2 年时,与未发生 HDP 的女性相比,经历过 HDP 的女性有心血管异常,左心室收缩和舒张功能下降,经多变量分析后仍存在。纵向分析表明,HDP 和非 HDP 组的心血管变化演变相似。
轻度的心脏功能和形态改变先于 HDP 的发生,这些改变至少持续到产后 2 年。心脏变化可能是母体心血管危险因素的结果,而不是 HDP 的不良后果。